Vincent O'Neill insider trades: BioXcel Therapeutics (BTAI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vincent reports to the SEC
Open-market buys and sales
10 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | BTAI | ↓ Sell | 165 | $0.35 | $58 | Direct | Dec 17, 2024 (1d) |
| Oct 3, 2024 | BTAI | ↓ Sell | 5,556 | $0.55 | $3K | Direct | Oct 3, 2024 (0d) |
| Sep 16, 2024 | BTAI | ↓ Sell | 138 | $0.69 | $95 | Direct | Sep 17, 2024 (1d) |
| Jun 17, 2024 | BTAI | ↓ Sell | 155 | $1.28 | $199 | Direct | Jun 18, 2024 (1d) |
| Apr 4, 2024 | BTAI | ↓ Sell | 165 | $2.62 | $432 | Direct | Apr 8, 2024 (4d) |
| Mar 15, 2023 | BTAI | ↓ Sell10b5-1 | 845 | $19.70 | $17K | Direct | Mar 16, 2023 (1d) |
| Jan 20, 2023 | BTAI | ↓ Sell | 29,713 | $30.00 | $891K | Direct | Jan 24, 2023 (4d) |
| Feb 17, 2021 | BTAI | ↓ Sell | 25,000 | $55.58 | $1.4M | Direct | Feb 19, 2021 (2d) |
| Jan 19, 2021 | BTAI | ↓ Sell | 25,000 | $49.47 | $1.2M | Direct | Jan 21, 2021 (2d) |
| Dec 28, 2020 | BTAI | ↓ Sell | 25,000 | $51.45 | $1.3M | Direct | Dec 30, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BTAI insiders
Open-market trades in the last 12 months
About Vincent O'Neill's insider trades
Vincent O'Neill is See Remarks at BioXcel Therapeutics (BTAI). Since Dec 28, 2020, Vincent has reported no open-market purchases and 10 sales worth $4.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (12 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.